DROPPER A1C DIABETES CONTROL— 510(k) K103744

Name: FDA 510(k) clearance K103744
Creator: U.S. Food and Drug Administration
Published: 2011-05-12

Substantially Equivalent

Quantimetrix Corp.

FDA 510(k) clearance K103744 for DROPPER A1C DIABETES CONTROL, Substantially Equivalent on 2011-05-12. Applicant: Quantimetrix Corp.. Device class: 1.

Clearance details

Applicant: Quantimetrix Corp.
Product code: Code JJX
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 2010-12-23
Decision date: 2011-05-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Redondo Beach, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJX

view all

K170678 — Beta-CrossLaps CalCheck 52017-04-04
K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
K162514 — Multichem A1c2016-10-26
K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

More clearances from Quantimetrix Corp.

view all

K142262 — AUTION CHECK PLUS2015-04-10
K113177 — COMPLETE D 25-OH VITAMIN D CONTROL2012-05-10
K062942 — QUANTIMETRIX NICOSURE COTININE URINE CONTROL2006-10-30
K062751 — MODIFICATION TO QUANTIMETRIX CARDIASURE CARDIAC MARKER2006-10-03
K060417 — MODIFICATION TO QUANTIMETRIX URINE DRUGS OF ABUSE CONTROL2006-03-21

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.